Clinical Trial Update: Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Socheongryong-tang and Yeongyopaedok-san for upper respiratory tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Socheongryong-tang
• Yeongyopaedok-san

Snippet

Sponsor: Korea Health Industry Development Institute | Conditions: Upper Respiratory Tract Infections | Phase 3 | Status: COMPLETED